Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2021-10-24 Legal Proceedings Report
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
VRT:Update on ACCC Court application on proposed acquisition 1
Legal Proceedings Report Classification · 95% confidence The document is an ASX announcement dated 25 October 2021 from Virtus Health Limited providing an update on the ACCC's court application regarding Virtus' proposed acquisition of Adora Fertility and day hospitals. It discusses a legal proceeding and court decision related to the acquisition but does not contain financial statements, detailed financial data, or a full report. The content is focused on legal proceedings and regulatory updates about the acquisition process. Therefore, it fits best under Legal Proceedings Report (LTR). The document length is short and it is not a report publication announcement or a certification. Hence, the classification is LTR with high confidence.
2021-10-24 English
Sale of Adora Fertility - update 1 page 462.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement regarding an update on the sale of Adora Fertility, specifically mentioning a Federal Court decision and an interlocutory injunction. It is a brief update on a legal matter related to a transaction but does not contain financial statements, detailed financial data, or comprehensive report content. The document is short (1605 characters) and serves as a regulatory announcement about ongoing legal proceedings affecting a sale transaction. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a full legal proceedings report but an update on a legal matter. Given the nature and length, the best fit is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2021-10-24 English
Trading Update 1QFY22 3 pages 504.9KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 21 October 2021 titled '1QFY22 Trading Update' for Healius Limited. It provides detailed financial and operational performance data for the first quarter of fiscal year 2022, including revenue, EBIT, and business segment updates. The content includes unaudited financial results, commentary on business trends, and outlook statements. It is a comprehensive quarterly update with substantive financial data and analysis, not merely a brief earnings highlight or a report publication announcement. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2021-10-20 English
AGM 2021 Chair's speech 5 pages 321.0KB
AGM Information Classification · 95% confidence The document is titled 'HEALIUS LIMITED ANNUAL GENERAL MEETING 2021 CHAIR’S SPEECH' and contains detailed remarks from the Chairman at the 2021 Annual General Meeting (AGM). It discusses procedural matters for the AGM, introduces board members, and covers topics such as company performance, strategic updates, remuneration, and board composition. The content is typical of AGM presentations and speeches rather than a full financial report or regulatory filing. The document length is about 15,000 characters, which is consistent with a detailed AGM speech but not a full Annual Report or financial statements. There is no indication that this is a transcript of a call, audit report, or other filing types. Therefore, the document best fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM.
2021-10-20 English
AGM 2021 CEO's speech 6 pages 313.5KB
AGM Information Classification · 95% confidence The document is titled 'HEALIUS LIMITED ANNUAL GENERAL MEETING 2021 CEO’s SPEECH' and contains a detailed speech by the CEO addressing the company's performance, strategy, operational updates, leadership changes, and trading results. It references the Annual General Meeting (AGM) and includes remarks typically delivered during such meetings. The content is a presentation or speech given at the AGM rather than a full annual report or financial statement. The length is substantial but the nature of the content aligns with AGM materials rather than a formal Annual Report (10-K) or Interim Report (IR). Therefore, the document fits the category of AGM Information (AGM-R).
2021-10-20 English
2021 AGM Presentation 19 pages 2.8MB
Regulatory Filings
2021-10-20 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.